Be invested in Sun Pharma, Cipla, Dr Reddy’s: Sukhani

Technical Analyst, Sudarshan Sukhani is of the view that it is safer to stick with Sun Pharma, Cipla, Dr Reddys Laboratories and Ranbaxy Laboratories all four are promising higher returns.

Sukhani told CNBC-TV18, “Aurobindo Pharma has recovered after a very sharp earlier decline but the point is do you want to buy this as a buying opportunity or do you want to stay with Sun Pharma, Cipla, Dr. Reddy’s and Ranbaxy the big four and when we see midcap Pharma my sense always is that because of the excellent performance of the top pharma stocks, its far easier and safer to stick with them all four are promising higher returns."